Rapid research advances, an increasingly globalised market and a complex regulatory environment necessitate innovative strategies to source and evaluate new technologies in the biotechnology and pharmaceutical fields.

biologyAt Cam2, we leverage our network and harness the expertise across industry and academia to analyse technical, commercial and legal hurdles and enable our clients to capture value in this challenging but rewarding sector.

We work collaboratively with our clients to develop a strong understanding of their internal R&D piplines and aquisition processes to deliver a tailor made service and enable growth in specific domains.


We are looking for new therapies targeting all major cancer types including Blood cancer, Breast cancer, gastrointestinal tract cancer, Prostate cancer, Lung Cancer, Skin Cancer and other cancer types.

Cardiovascular Disease

Cardiovascular disorders are the major cause of death in developed countries. We are looking for assets in all major disease areas including heart and blood vessels disorders, stroke, asischemic heart disease, dyslipidemia, thrombosis, atherosclerosis, coronary artery diseases, peripheral artery disease and others.

Neurological Disorders

We are looking for assets in all major areas including Alzheimer’s disease, dementia, migraine, Huntington’s disease, movement disorders, epilepsy and others.

Infectious diseases

We are interested in innovative companies developing new anti-infective therapies, focused both on targeting the pathogen as well as enabling the host immune system to respond more effectively.